Streetbeat News

Stock Prices

TSLA

Elon Musk's tweet featuring a video of Tesla's humanoid robot, Optimus, caused a 25% surge in the price of the memecoin Optimus AI (OPTI). Blockchain entrepreneur Bruno Volcovinsky commented on the quick money-making opportunity this presents for investors. Crypto analyst Tiredwtf noted Musk's significant influence on crypto prices, referencing past surges in Dogecoin and other Elon-inspired coins. However, the price of OPTI has since corrected, falling back to around 20 cents.

Portfolio Pulse from Murtuza Merchant

January 31, 2024 | 10:22 pm

KPRX

Trading for KPRX has been halted at 5:10:00 p.m. ET due to pending news. The halt is in place to manage market orderliness and investor protection pending the release of material news.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:10 pm

NTLA

Intellia Therapeutics announced the publication of interim Phase 1 data for NTLA-2002 in the New England Journal of Medicine, showing its potential to eliminate angioedema attacks in patients with hereditary angioedema (HAE) after a single dose. The data also indicated that NTLA-2002 was well-tolerated across all dose levels.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:09 pm

CTVA

Corteva, an agriculture company, has provided its financial outlook for 2024, projecting net sales of $17.4 billion to $17.7 billion, which is in line with the estimated $17.608 billion. However, the company's adjusted earnings per share (EPS) forecast of $2.70 to $2.90 falls short of the estimated $3.01.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:07 pm

CTVA

Corteva, Inc. has announced its intention to repurchase approximately $1.0 billion of its shares in 2024. This buyback plan reflects the company's confidence in its financial strength and commitment to delivering value to its shareholders.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:04 pm

CTVA

Corteva (NYSE:CTVA) reported Q4 adjusted earnings per share (EPS) of $0.15, surpassing the analyst consensus estimate of $0.06 by 150%. However, this represents a 6.25% decrease from the $0.16 EPS reported in the same quarter last year. Sales reached $3.71 billion, exceeding the $3.62 billion estimate by 2.40%, but marking a 3.08% decline from the $3.83 billion in sales reported in the same period the previous year.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:03 pm

RNAZ

TransCode Therapeutics has regained compliance with Nasdaq's listing requirements. Previously, the company was at risk of being delisted due to non-compliance with the minimum bid price requirement. The company's stock, RNAZ, is now back in compliance, which is positive news for investors and the company's continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 9:55 pm

AAPL

QCOM

Qualcomm has extended its licensing agreement with Apple until March 2027, ensuring a continued partnership between the two tech giants for the next several years.

Portfolio Pulse from Charles Gross

January 31, 2024 | 9:54 pm

RKLB

Rocket Lab USA Inc (RKLB) shares dropped after announcing a private offering to raise $275 million through convertible senior notes due 2029. The proceeds will fund capped call transactions and repay part of its equipment financing. This follows preliminary Q4 results with expected revenues of $59-$61 million, gross margins of 24.8%-26.8%, and a net loss of $49-$52.5 million. The company's stock fell 2.61% and an additional 12.01% after hours.

Portfolio Pulse from Adam Eckert

January 31, 2024 | 9:54 pm

SNCY

Sun Country Airlines projects its Q1 2024 revenue to be between $310M and $320M, which is in line with the estimated $311.889M by analysts.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 9:53 pm